Amexdrug Corporation
AXRX
$0.002
$0.000.00%
| 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | |
|---|---|---|---|---|---|
| Net Income | 165.90K | 150.30K | 82.10K | -35.20K | 11.40K |
| Total Depreciation and Amortization | 50.00K | 34.80K | 19.60K | 10.10K | 9.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.80K | -14.70K | -15.50K | -16.40K | -13.50K |
| Change in Net Operating Assets | -270.80K | -483.40K | -246.80K | -596.90K | 3.60K |
| Cash from Operations | -74.90K | -313.20K | -160.90K | -638.70K | 10.60K |
| Capital Expenditure | -461.00K | -461.00K | -458.60K | -14.10K | -31.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.70K | 1.30K | -2.00K | -600.00 | -600.00 |
| Cash from Investing | -459.30K | -459.70K | -460.60K | -14.70K | -31.70K |
| Total Debt Issued | 809.80K | 459.80K | 459.80K | 786.40K | 321.30K |
| Total Debt Repaid | -203.80K | 323.50K | 0.00 | 113.20K | -357.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.60K | -1.20K | -900.00 | -2.30K | -2.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -11.00K | -11.00K | -11.00K | 12.40K | 11.60K |
| Cash from Financing | 593.30K | 771.00K | 447.90K | 909.60K | -26.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 59.20K | -1.70K | -173.50K | 256.20K | -47.80K |
